Plain-English translation of NCT07669779 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called AK146D1 to see if it works better when combined with other existing cancer treatments for advanced lung cancer. Researchers want to understand whether this combination is safe and how well it helps patients. The study will compare three different drug combinations to find out which works best.
Advanced lung cancer is difficult to treat, and many patients need better options than what's currently available. This trial is exploring whether this new treatment could offer patients a more effective way to manage their disease.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic regularly to receive the medication through an IV infusion and have blood tests and scans to monitor how you're responding. Depending on which study group you're assigned to, you would receive AK146D1 combined with either another newer drug, a targeted therapy, or chemotherapy plus another drug. Throughout the study, your doctors will carefully track your health and any side effects you experience to make sure the treatment is working safely.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
China